Ajay Kumar/LinkedIn
Mar 2, 2026, 16:09
Ajay Kumar: The Progression of HDFN – From Fetal Anemia to Kernicterus
Ajay Kumar, Senior Resident at Geetanjali Hospital, shared a post on LinkedIn:
“As a transfusion medicine specialist, I often emphasize the importance of early Antibody Screening in pregnancy.
Haemolytic Disease of the Fetus and Newborn (HDFN) is a preventable yet potentially life-threatening condition.
Timely antenatal antibody screening, appropriate monitoring, and interventions like intrauterine transfusion (IUT) or phototherapy can save lives and prevent permanent neurological damage.
Prevention and vigilance remain our strongest tools.”
Stay updated with Hemostasis Today.
-
Jul 19, 2026, 14:01Jecko Thachil: Should We Focus on Sustainable Thromboprophylaxis?
-
Jul 19, 2026, 13:50Romiya Glover Barry: The Conversations That Shape Better Healthcare at ISTH 2026
-
Jul 19, 2026, 13:36Kellie Machlus: CCL5 as a Driver of Megakaryopoiesis and Platelet Recovery
-
Jul 19, 2026, 13:13Neha Jodhawat: Advancing Precision Medicine in Immune Thrombocytopenia at ISTH 2026
-
Jul 19, 2026, 11:59Elena Petkovic: Turning Scientific Exchange into Clinical Progress at ISTH 2026
-
Jul 19, 2026, 11:34Obstetric Antiphospholipid Syndrome Beyond Anticoagulation: Toward Precision Obstetric Hemostasis
-
Jul 19, 2026, 11:20Jennifer Pott: A Rewarding End to an Inspiring Conference at ISTH 2026
-
Jul 19, 2026, 11:10Pablo Albasanz-García: The Conversations That Shape Better Science at ISTH 2026
-
Jul 19, 2026, 10:55Alessia Abenante: Grateful for the Recognition and Connections at ISTH 2026